Table 9.

S-values (in units of mGy MBq⁻¹ s⁻¹) for Sr-90, Sr-89, Y-90, P-32, P-33, Ca-45, and Ho-166 calculated for various skeletal source–target regions in the skeleton of the ICRP reference adult female based upon skeletal-averaged specific absorbed fractions from the present study, the UF adult male odel of Hough et al (2011), and the adult female model from OLINDA (Stabin et al., 2005). Both mean and maximum beta-particle energies are listed in parentheses.

UF Models	OLINDA 2005	Sr-90 (196 keV/546 keV)			Sr-89 (585 keV/1460 keV)			Y-90 (933 keV/2280 keV)			Ca-45 (77 keV/257 keV)			P-32 (695 keV/1710 keV)			P-33 (76 keV/249 keV)			Ho-166 (665 keV/1854 keV)
S Value (mGy/MBq-s)	S Value (mGy/MBq-s)	UF Adult Female	UF Adult Male	OLINDA Adult Female	UF Adult Female	UF Adult Male	OLINDA Adult Female	UF Adult Female	UF Adult Male	OLINDA Adult Female	UF Adult Female	UF Adult Male	OLINDA Adult Female	UF Adult Female	UF Adult Male	OLINDA Adult Female	UF Adult Female	UF Adult Male	OLINDA Adult Female	UF Adult Female	UF Adult Male	OLINDA Adult Female
Targets - Surrogate Tissues for the HSC
S (AM←AM)	S (AM←AM)	1.74E–05	1.32E–05	1.26E–05	4.32E–05	3.31E–05	3.34E–05	6.23E–05	4.82E–05	5.23E–05	8.33E–06	6.46E–06	6.07E–06	5.01E–05	3.84E–05	3.94E–05	8.3E–06	6.4E–06	6.0E–06	4.8E–05	4.0E–05	4.0E–05
S (AM←IM)	S (AM←IM)	6.25E–06	2.47E–06	NA	1.70E–05	6.90E–06	NA	2.51E–05	1.04E–05	NA	2.29E–06	8.79E–07	NA	1.99E–05	8.10E–06	NA	2.3E–06	8.7E–07	NA	1.9E–05	8.0E–06	NA
S (AM←TBS)	S (AM←TBS)	7.09E–06	5.34E–06	6.74E–06	2.11E–05	1.62E–05	2.46E–05	3.15E–05	2.44E–05	4.01E–05	2.50E–06	1.85E–06	2.35E–06	2.48E–05	1.91E–05	2.95E–05	2.5E–06	1.8E–06	2.3E–06	2.4E–05	1.9E–05	2.9E–05
S (AM←TBV)	S (AM←TBV)	4.00E–06	3.75E–06	5.02E–06	1.46E–05	1.37E–05	2.29E–05	2.23E–05	2.10E–05	3.84E–05	7.68E–07	7.21E–07	5.62E–07	1.74E–05	1.63E–05	2.78E–05	7.4E–07	6.9E–07	5.5E–07	1.6E–05	1.6E–05	2.7E–05
S (AM←CBS)	S (AM←CBS)	4.03E–07	2.23E–07	0.00E+00	2.90E–06	1.95E–06	1.63E–10	5.34E–06	4.11E–06	0.00E+00	5.61E–08	2.70E–08	0.00E+00	3.66E–06	2.54E–06	0.00E+00	5.4E–08	2.6E–08	0.0E+00	3.5E–06	2.5E–06	5.6E–08
S (AM←CBV)	S (AM←CBV)	3.96E–07	2.59E–07	0.00E+00	2.91E–06	2.27E–06	1.63E–10	5.38E–06	4.79E–06	0.00E+00	5.21E–08	3.14E–08	0.00E+00	3.68E–06	2.95E–06	0.00E+00	5.0E–08	3.0E–08	0.0E+00	3.5E–06	2.9E–06	5.6E–08
Targets – Surrogate Tissues for the OPC
S (TM50←AM)	S (TBE←AM)	1.04E–05	5.92E–06	1.02E–05	2.90E–05	1.68E–05	3.10E–05	4.29E–05	2.50E–05	4.98E–05	4.37E–06	2.45E–06	3.96E–06	3.39E–05	1.97E–05	3.69E–05	4.3E–06	2.4E–06	3.9E–06	3.2E–05	2.0E–05	3.7E–05
S (TM50←IM)	S (TBE←IM)	1.01E–05	3.33E–06	NA	2.87E–05	9.65E–06	NA	4.34E–05	1.48E–05	NA	4.23E–06	1.40E–06	NA	3.37E–05	1.14E–05	NA	4.2E–06	1.4E–06	NA	3.2E–05	1.1E–05	NA
S (TM50←TBS)	S (TBE←TBS)	2.23E–05	1.09E–05	2.19E–05	4.35E–05	2.03E–05	3.75E–05	6.14E–05	2.81E–05	5.50E–05	1.44E–05	7.61E–06	1.90E–05	4.97E–05	2.29E–05	4.32E–05	1.4E–05	7.6E–06	1.9E–05	4.8E–05	2.6E–05	5.2E–05
S (TM50←TBV)	S (TBE←TBV)	1.38E–05	7.23E–06	1.29E–05	3.59E–05	1.82E–05	3.14E–05	5.23E–05	2.66E–05	4.89E–05	4.61E–06	2.80E–06	5.44E–06	4.18E–05	2.11E–05	3.70E–05	4.5E–06	2.8E–06	5.4E–06	4.0E–05	2.1E–05	3.8E–05
S (TM50←CBS)	S (CBE←CBS)	7.77E–07	6.50E–06	1.65E–05	4.20E–06	8.29E–06	3.23E–05	7.88E–06	1.08E–05	4.82E–05	1.02E–07	5.49E–06	1.46E–06	5.28E–06	8.95E–06	3.75E–05	3.0E–07	5.5E–06	1.6E–05	4.9E–06	1.2E–05	4.6E–05
S (TM50←CBV)	S (CBE←CBV)	5.80E–07	3.64E–07	6.55E–06	3.77E–06	2.65E–06	2.21E–05	7.09E–06	5.61E–06	3.51E–05	2.97E–07	7.43E–08	1.57E–05	4.76E–06	3.43E–06	2.62E–50	9.9E–08	7.3E–08	1.4E–06	4.5E–06	3.4E–06	2.6E–05